COVID-19 Records

Reading Room Production — page 132

of 496 pages

← p.131 p.133 → · this page in the original PDF · package

ol y (9/27), ) 7PM AID DEA DART NIAID) [E] 7 NIAID) [E] \IH/NIAID) [E] ii a NIH/NIAID) [E] VIH/NIAID) [E] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] DMID has suggested comments in highlighted Ww. Please let me know if you have any questions. i) 4PM [AID DEA DART ID DIR-OCGR < ACTION: By COB Friday (9/27), please review the attached redline and provide any new comments directly in the document. Thanks, Chase From: Selgrade, Sara (NIH/NIAID) [E] @nih.gov> Sent: Tuesday, July 16, 2024 6:07 PM To: NIAID BUGS @niaid.nih.gov>; NIAID DEA DART @mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR- @mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E] @nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E] @niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E] @niaid.nih.gov> Cc: NIAID OCGR Leg @mail.nih.gov>; Erbelding, Emily (NIH/NIAID) [E] @nih.gov>; Holland, Steven (NIH/NIAID) [E] @niaid.nih.gov>; Hanson, Christopher (NIH/NIAID) [E] @niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E] @nih.gov>; Gilles, Sharon (NIH/NIAID) [E] @nih.gov>; DDSM Correspondences @mail.nih.gov> Subject: URGENT review by 8am Wed. 7/17: HHS Comments to OMB on Risky Research Review Act Importance: High Hello all, Thank you for your review of the consolidated HHS comments on the Risky Research Review Act. DMID has suggested adding some of the comments NIAID put forward earlier this week. We have incorporated these comments in highlighted text in the attached document. The comments are listed below by page number for ease of review. Please let us know by no later than 8am tomorrow, Wednesday, July 17th, if you have any concerns with putting forward these previously NIAID-cleared edits. Thank you again for all your help with this quick turnaround request. Please let me know if you have any questions. Thanks, Sara Re-submitted NIAID comments in the attached document (highlighted in yellow): p. 1: New NIH comment p. 2: NIH addition to OASH/OHRP comment p. 3: New NIH comment p. 4: NIH addition to OASH/OHRP comment p. 9: NIH edit to OGC comment to broaden scope to all agencies (previously flagged by OCGR-Leg) p. 10: NIH addition (from NIAID) to existing NIH comment p. 12: NIH addition to OIG comment p. 14: NIH addition to OGC comment p. 16: NIH addition (from NIAID) to existing NIH comment From: Selgrade, Sara (NIH/NIAID) [E] @nih.gov> Sent: Tuesday, July 16, 2024 12:24 PM To: NIAID BUGS @niaid.nih.gov>; NIAID DEA DART @mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIRReleased by Chairman Rand Paul

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/reading_room/132

Records on this page

RecordDateTypePages
reading_room:email:00134 2024-07-16 email 132–133
URGENT review by 8am Wed. 7/17: HHS Comments to OMB on Risky Research Review Act 2024-07-16 email 132
ACTION by COB Friday (9/27): Review revised bill text for Risky Research Review Act 2024-09-25 email 131–132